Endothelial modulation of a nitric oxide donor complex-induced relaxation in normotensive and spontaneously hypertensive rats

Life Sci. 2018 May 15:201:130-140. doi: 10.1016/j.lfs.2018.03.055. Epub 2018 Mar 28.

Abstract

We hypothesized that endothelium modulates relaxation induced by a nitric oxide (NO) donor ruthenium complex (TERPY, [Ru(terpy)(bdq)NO]3+) in mesenteric arteries of normotensive and spontaneously hypertensive (SHR) rats in different ways. We analyzed the mechanism involved in TERPY-induced relaxation in the second and third branches of mesenteric arteries and investigated how endothelium contributes to the TERPY vasodilator effect on SHR blood vessels. TERPY induced concentration-dependent relaxation in endothelium-denuded (E-) and endothelium-intact (E+) mesenteric arteries of normotensive rats and SHR. Pretreatment with ODQ (which inhibits soluble guanylyl cyclase) or TEA (tetraethylammonium, which blocks potassium channels) significantly reduced the TERPY vasodilator effect on E- mesenteric arteries of normotensive rats and SHR. The presence of endothelium shifted the concentration-effect curves for TERPY in E+ mesenteric arteries of normotensive rats to the right. Conversely, the presence of endothelium shifted the concentration-effect curves for TERPY in the case of SHR E+ mesenteric arteries to the left, which suggested increased potency. L-NNA, a more selective endothelial NO synthase (eNOS) inhibitor, reduced TERPY potency in SHR. The presence of endothelium and notably of NOS contributed to the TERPY vasodilator action in SHR: TERPY promoted eNOS Ser1177 phosphorylation with consequent NO production and increased soluble guanylyl cyclase activity, which may have directly activated potassium channels.

Keywords: Mesenteric artery; Nitric oxide donor; SHR; TERPY; eNOS.

MeSH terms

  • Animals
  • Coordination Complexes / pharmacology*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects*
  • Guanylate Cyclase / antagonists & inhibitors
  • Male
  • Mesenteric Arteries / drug effects
  • Muscle Relaxation / drug effects*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide Donors / pharmacology*
  • Nitric Oxide Synthase Type III / antagonists & inhibitors
  • Oxadiazoles / pharmacology
  • Potassium Channel Blockers / pharmacology
  • Quinoxalines / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Ruthenium / chemistry*
  • Vascular Resistance / drug effects
  • Vasodilation / drug effects

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Coordination Complexes
  • Nitric Oxide Donors
  • Oxadiazoles
  • Potassium Channel Blockers
  • Quinoxalines
  • Ruthenium
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Guanylate Cyclase
  • NG-Nitroarginine Methyl Ester